British Liver Transplant Group
The BLTG (British Liver Transplant Group) was launched in 2014 to represent the professional interests of liver transplantation in the UK and promote strategic and academic development.
The BLTG will foster close relationships with BTS (British Transplant Society) and LICAGE (Liver Intensive Care Group of Europe) and will build on the role of the UK and Ireland Annual Meeting by delivering structure and authority to the group.
BLTG Transplant Meetings
The annual BLTG meeting usually integrates the meetings previously organised by each individual transplant centre but will extend to the many individuals working outwith liver transplant centres with an interest in liver transplantation. The meeting offers a platform for those operating in or with a strong interest in the field of liver transplantation. The BLTG Transplant meeting usually links to the BASL Annual Meeting and is aligned to the Liver Transplant Symposium and Williams-Calne Lecture within that programme. The winner of the Andy Burroughs Young Investigator Award will also deliver their prize lecture during the BLTG meeting.
BLTG 2021 - this year's Annual Meeting will take place virtually on Tuesday 21st September as part of the BASL Annual Meeting. Registration is open and a programme available on the Events page of the website.
The BASL BLTG School of Transplantation offers an excellent platform for trainees with lectures delivered by carefully selected leading speakers from the UK.
The Work of the BLTG
BLTG will provide a voice for UK liver transplantation bringing together all clinicians and allied personnel involved or interested in liver transplantation in the UK. By working closely with allied bodies such as the Liver Advisory Group to NHSBT, the British Transplant Society, BASL, BSG, AUGIS and LICAGE, BLTG will provide the professional view on aspects of planning and delivering liver service for the UK, including liver transplantation. There will also be a strong emphasis on education and training and setting out the future needs of UK Liver services / transplantation.
BLTG Committee Elections 2021 - Closed
A number of posts on the British Liver Transplant Group (BLTG) Committee will come to the end of tenure in September 2021 and we are seeking expressions of interest for the following positions on the committee:
BLTG Chair Elect
Elected by the BASL BLTG membership to serve for 1 year and take over from the BLTG Chair after the BASL Annual Business Meeting in September 2022. The BLTG Chair sits on the BASL Governing Board and is registered with Companies House in the UK as a Director of BASL.
Elected by the BASL BLTG membership to serve for a period of up to three years and may be re-elected once.
BLTG Conference and Education Lead
Elected by the BASL BLTG members for a term of 2 and 3 years alternating - this is a 2 year post.
Nursing Representative (x2 posts); Transplant Co-ordinator and Nursing Representative
Elected by the BASL BLTG membership and will serve for a period of two years. The nursing representatives on the committee represent patient care before and after liver transplantation respectively.
Any BASL member who wishes to be affiliated to BLTG can do so via the 'member area' of the BASL website or by emailing email@example.com .
Please send your nominations by email, clearly stating the position that your nomination is for, to the BASL Secretariat firstname.lastname@example.org by the deadline of 09:00 on Friday 30th July 2021.
Candidates wishing to be considered to join the BLTG Committee will require one BASL/BLTG member to propose them and a second BASL/BLTG member to confirm their suitability for the role in writing. (Proposing and seconding of candidates is by email.)
If more than one candidate is nominated for one or more of the posts, the Secretariat will arrange for an election of BASL BLTG members. A personal statement, containing no more than approx. 300 words, will be requested from the candidates. He/she will be elected by a simple majority of BASL BLTG members voting.
The BLTG Committee
|BLTG Chair||Dr Varuna Aluvihare, Kings College Hospital, London|
|BLTG Past Chair||Professor Derek Manas, Freeman Hospital, Newcastle upon Tyne|
|BLTG Secretary||Dr Andrew Holt, Queen Elizabeth Hospital, Birmingham|
|Conference and Education Lead||Dr Joanna Leithead, Addenbrookes Hospital, Cambridge|
|Transplant Hepatology representative||Dr Steven Masson, Freeman Hospital, Newcastle Upon Tyne|
|Transplant Surgery Representative||Professor Brian Davidson, Royal Free Hospital, London|
|Pathology representative||Dr Tim Kendall, University of Edinburgh and Royal Infirmary of Edinburgh|
|Pharmacy representative||Claire Bullen, Addenbrookes Hospital, Cambridge|
|BSG representative||Mhairi Donnelly, Consultant Hepatologist, Freeman Hospital, Newcastle upon Tyne|
|Nursing Representative||Katie Ramos, Derriford Hospital, Plymouth|
|Paediatric representative||Dr Eirini Kyrana, Clinical Senior Lecturer & Honorary Consultant in Paediatric Hepatology, Kings College Hospital, London
|Patient Representative||Martine Walmsley, PSC Support|
|Patient Representative||Sarah Barker|
|BASL representative (Treasurer)||James Ferguson, Queen Elizabeth Hospital, Birmingham|
|BTS Representative||Anya Adair, NHS Lothian|
|Substance misuse specialists (SMSLT) representative||Charlie Parker, University Hospitals Birmingham|
|Interventional Radiology representative||Dr Jai Patel, Leeds Teaching Hospital|
|Anaesthetic Representative||Dr Suehana Rahman, Royal Free Hospital, London|
||Dr Brian Hogan, Kings College, London|
|Research Strategy Lead||Dr Matt Armstrong, University Hospital, Birmingham|
Dr Varuna Aluvihare, King’s College Hospital, London
Dr Aluvihare is Transplant Hepatology and Governance Lead at the Institute of Liver Studies, King’s College Hospital, and Chair of the British Liver Transplant Group. He qualified at the Royal Free Hospital and completed his professional training at Addenbrooke’s Hospital, Cambridge. He undertook MRC funded Training (PhD) and Clinician Scientist fellowships in Immunology/Molecular Biology at the world renowned MRC Laboratory of Molecular Biology, University of Cambridge. He was awarded a 5-year HEFCE Senior Lecturer Fellowship and an ROTRF grant in transplantation research at King’s College Hospital. He is a member of the UK Liver Transplant Advisory Group, Hepatology representative on the National Multivisceral Transplantation Review Group, Transplant Hepatology representative on the British Transplant Society Council and a member of the Editorial Board for Liver Transplantation.
Professor Derek Manas, Freeman Hospital, Newcastle upon Tyne
Professor Manas is a Consultant HPB and Transplant Surgeon, Newcastle upon Tyne. He is a Professor of Transplantation Surgery and Director of the Institute of Transplantation at the Freeman Hospital, Newcastle upon Tyne. Professor Manas trained in Cape Town, Johns Hopkins and Paris. He is President Elect of the British Transplant Society and Chair of the Transplant Surgeons Chapter. His interests cover the Management of HCC, Surgical Management of Hilar Cholangiocarcinama, Ablative therapies for Liver and Pancreas Tumours and the use of Marginal organs for Transplantation.
Dr Andrew Holt, Queen Elizabeth Hospital, Birmingham / University of Birmingham
Dr Holt is a Consultant Physician and Transplant Hepatologist based at the Liver Unit in Queen Elizabeth Hospital, Birmingham and a Senior Researcher at the University of Birmingham. Andrew moved to the Birmingham Liver Transplant Unit in 2002 and was the Clinical Service Lead until 2018. His particular interests are in addiction-related liver disease and transplantation and he leads the multidisciplinary High Intensity Clinic for complex disease management. His research interests are predominantly based around the management of decompensated liver disease and he holds a PhD from the University of Birmingham for his work studying stromal immune interactions within the liver.
Dr Joanna A Leithead, MBChB MD MRCP, Consultant in Hepatology and Liver Transplantation, Addenbrookes Hospital Cambridge
Dr Joanna A Leithead, MBChB MD MRCP is a Consultant in Hepatology and Liver Transplantation in Addenbrookes Hospital, Cambridge, UK. She has more than 10 years of experience in transplant centres, including 3 years in the Royal Infirmary of Edinburgh researching aspects of portal hypertension and 5 years as the Clinical Lecturer in Hepatology in the Queen Elizabeth Hospital Birmingham. Her main active research focus is the role that liver graft injury plays in the development of renal injury. Her clinical interests are complications of portal hypertension and liver transplantation. She is a member of the NHSBT Liver Advisory Group, and the Conference and Education Lead for the British Liver Transplant Group.
Dr Steven Masson, Consultant in Hepatology and Liver Transplantation, Freeman Hospital, Newcastle Upon Tyne
Dr Masson is a Consultant Hepatologist at the regional Liver and Transplant Unit at the Freeman Hospital, Newcastle and Institute of Cellular Medicine, Newcastle University. His clinical and research interests are focused around alcohol-related liver disease, haemochromatosis and liver transplantation. He is the Hepatology speciality group lead for the North East and Cumbria LCRN. He is the consultant lead for the alcohol liaison team at the Newcastle Hospitals. He graduated from Edinburgh University and subsequently trained in hepatology and liver transplantation in Edinburgh, Newcastle and London.
Professor Brian Davidson, Royal Free Hospital, London
Professor Davidson is a consultant surgeon with a major interest in HPB surgery and liver transplant. He is UK editor of the Cochrane HPB group for evidence based healthcare and director of the UCL MSc in evidence based medicine. He works closely with patient groups on research advances in the HPB field and leads a research programme involving evidence based healthcare, organ preservation and tissue engineering, image guided surgery and novel approaches to the treatment of HPB cancers.
Dr Tim Kendall, Senior Clinical Fellow in Pathology, University of Edinburgh and Honorary Consultant Liver Pathologist, Royal Infirmary of Edinburgh
Dr Kendall's research interests are liver fibrogenesis and primary liver cancer but he provides histopathological support for many other preclinical, translational and clinical studies. He is a member of the UK Liver Pathology group research subcommittee, and he promotes histopathological involvement in trials through membership of the CM-Path Clinical Trials workstream, the NCRI Hepatobiliary CSG subgroup, and his role within the Lothian NRS Human Annotated Bioresource. Dr Kendall graduated from Southampton University Medical School, and trained in pathology in Southampton and Edinburgh.
Katie Ramos, Derriford Hospital, Plymouth
Katie Ramos qualified at St Georges Hospital/Kingston University. Shortly after she developed her interest in Hepatology Nursing when she moved to the Liver Intensive Care, Kings College Hospital. Following several years of experience she became a junior sister as well as being a member of the liver retrieval team. Following this she became a liver recipient transplant coordinator at Kings, focussing on pre transplant and waiting list management. In 2009 she took up her current post as Liver transplant coordinator at the South West Liver Unit, University Hospitals Plymouth. Here she has cemented her experience and knowledge in all aspects of care of liver transplants patients and manages their care throughout the transplant journey; seeing patients from the point of referral for assessment through to long term follow-up. Her role has evolved through this time taking on more extended roles including non-medical prescribing and is currently undertaking her masters in advanced clinical practice. Katie co-leads on transition for the unit and is an integral part of the south west liver nurse group focussing on providing education to ward nurses as well as supporting patient inclusion via social media and advocating peer support.
Dr Eirini Kyrana, Leeds Teaching Hospital
Dr Eirini Serena Kyrana is a Consultant in Paediatric Hepatology at the Children's Liver Unit at the Leeds Children's Hospital and Honorary Senior Lecturer at the University of Leeds. Her training in hepatology has been at King's College Hospital and in gastroenterology and nutrition at Great Ormond Street Hospital. She looks after children with acute and chronic liver disease, as well as with end stage liver disease before and after liver transplantation. She has a strong interest in nutritional issues, metabolism and body composition of children with chronic liver disease and has an MDRes with King's College London looking at body composition and metabolic profiles of children with end stage liver disease.
Dr Jai Patel, Leeds Teaching Hospitals NHS Trust (LTHT)
Dr Patel was appointed as consultant in vascular and interventional radiology at LTHT in 1999. Together with other colleagues in the department he provides a comprehensive specialist vascular radiology service in a wide range of minimally invasive interventions. His main area of interest and expertise is in liver intervention, specifically in trans-arterial therapies for the treatment of liver tumours and interventional radiological management of portal hypertension (cirrhotic, non-cirrhotic and Budd-Chiari syndrome). His practice includes intervention in both adult and paediatric liver patients. He was previously Lead Clinician for vascular radiology at LTHT for 5 years and remains the lead interventionalist for the liver service in Leeds. Previous committee work has included Education Committee Chairman and Secretary of the British Society of Interventional Radiology. He also has an interest in the use of new medical devices and technologies in patient management, and is currently a committee member of the NICE Medical Technologies Advisory Committee.
Dr Suehana Rahman, Royal Free Hospital, London
Dr Rahman MBBS BSc (Hons) FRCA, is a Consultant Hepatobiliary and Liver Transplant Anaesthetist at the Royal Free Hospital, London. During her transplant fellowship she undertook research in cirrhotic cardiomyopathy and acute kidney injury after transplantation. She is an active member of the Royal Free Perioperative Research Group and current anaesthetic representative for the British Liver Transplant Group.
Dr Brian Hogan, Kings College, London
Dr Hogan qualified from University College London Medical School in 2004. He completed Specialist Training in Critical Care Medicine and Hepatology at King's College Hospital, The Royal Free Hospital and Guy's and St Thomas' Hospitals before joining King's as a Consultant in 2018. Whilst training he completed research at The Royal Free Hospital and University College London investigating novel methods of assessing portal hypertension in patients with severe liver disease. Dr Hogan works as a Consultant in both Critical Care Medicine and Hepatology.
Dr Matt Armstrong, University Hospital, Birmingham
Dr Armstrong is a consultant in Liver and Transplant Medicine at the Queen Elizabeth University Hospital Birmingham and Honorary Lecturer at the National Institute for Health Research Biomedical Research Centre at the University of Birmingham, UK. His main research interests include non-alcoholic fatty liver disease (NAFLD), lipotoxicity/obesity, cardiovascular risk, prehabilitation and physical frailty/sarcopenia in patients before and liver transplantation. He is a named author on more than 80 publications in his area of specialization and was awarded Dame Sheila Sherlock Award in 2016 for his bench-to-bedside research of GLP-1 in NAFLD. He currently co-runs the liver transplant waiting list clinic and evolving prehabilitation services in Birmingham.